These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36588791)

  • 1. A novel diagnostic model for predicting immune microenvironment subclass based on costimulatory molecules in lung squamous carcinoma.
    Duan F; Wang W; Zhai W; Wang J; Zhao Z; Zheng L; Rao B; Zhou Y; Long H; Lin Y
    Front Genet; 2022; 13():1078790. PubMed ID: 36588791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating machine learning algorithms and multiple immunohistochemistry validation to unveil novel diagnostic markers based on costimulatory molecules for predicting immune microenvironment status in triple-negative breast cancer.
    Zhang C; Zhai W; Ma Y; Wu M; Cai Q; Huang J; Zhou Z; Duan F
    Front Immunol; 2024; 15():1424259. PubMed ID: 39007147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative Analysis of Bioinformatics and Machine Learning Algorithms Identifies a Novel Diagnostic Model Based on Costimulatory Molecule for Predicting Immune Microenvironment Status in Lung Adenocarcinoma.
    Zhai WY; Duan FF; Wang YZ; Wang JY; Zhao ZR; Lin YB; Rao BY; Chen S; Zheng L; Long H
    Am J Pathol; 2022 Oct; 192(10):1433-1447. PubMed ID: 35948079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma.
    Wang Q; Chen Y; Gao W; Feng H; Zhang B; Wang H; Lu H; Tan Y; Dong Y; Xu M
    Front Oncol; 2022; 12():933925. PubMed ID: 35912252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implication and immunotherapy response prediction of a costimulatory molecule signature in kidney renal clear cell carcinoma.
    Lin G; Yang Y; Feng Q; Zhan F; Sun C; Niu Y; Li G
    Immunogenetics; 2022 Jun; 74(3):285-301. PubMed ID: 35119508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma.
    Yang Q; Gong H; Liu J; Ye M; Zou W; Li H
    Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing.
    Yang L; Wei S; Zhang J; Hu Q; Hu W; Cao M; Zhang L; Wang Y; Wang P; Wang K
    J Transl Med; 2022 Aug; 20(1):364. PubMed ID: 35962453
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wang T; Luo Y; Zhang Q; Shen Y; Peng M; Huang P; Zhou Z; Wu X; Chen K
    J Thorac Dis; 2022 Mar; 14(3):729-740. PubMed ID: 35399232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
    Aye L; Song X; Yang J; Hu L; Sun X; Zhou J; Liu Q; Yu H; Wang D
    Front Cell Dev Biol; 2021; 9():695533. PubMed ID: 34434928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy.
    Qiang H; Li J; Chang Q; Shen Y; Qian J; Chu T
    Front Oncol; 2022; 12():835225. PubMed ID: 35211415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma.
    Hu X; Guo L; Liu G; Dai Z; Wang L; Zhang J; Wang J
    Front Oncol; 2022; 12():997702. PubMed ID: 36465363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.
    Deng X; Wang Z; Luo Y; Li Z; Chen L
    Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell proliferation-related genes: Predicting prognosis, identifying the cold and hot tumors, and guiding treatment in clear cell renal cell carcinoma.
    Huang H; Cai Y; Hong X; Gao W; Tang J; Zhang S; Xu Z
    Front Genet; 2022; 13():948734. PubMed ID: 36118894
    [No Abstract]   [Full Text] [Related]  

  • 14. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma.
    Zhai WY; Duan FF; Chen S; Wang JY; Zhao ZR; Wang YZ; Rao BY; Lin YB; Long H
    Front Cell Dev Biol; 2022; 10():770550. PubMed ID: 35300428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors.
    Jang HJ; Lee HS; Ramos D; Park IK; Kang CH; Burt BM; Kim YT
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1598-1610.e3. PubMed ID: 31879171
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhang W; Zhang Q; Xie Z; Che L; Xia T; Cai X; Liu S
    Front Genet; 2022; 13():839957. PubMed ID: 35719401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of costimulatory molecules in glioma biology and immune microenvironment.
    Wang J; Wang Z; Jia W; Gong W; Dong B; Wang Z; Zhou M; Tian C
    Front Genet; 2022; 13():1024922. PubMed ID: 36437961
    [No Abstract]   [Full Text] [Related]  

  • 19. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
    Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
    World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of a prediction model for therapeutic response and prognosis based on chemokine signaling-related genes in stage I-III lung squamous cell carcinoma.
    Lai J; Yang S; Chu S; Xu T; Huang J
    Front Genet; 2022; 13():921837. PubMed ID: 36118890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.